Blackstone buys Japan drug trial firm, adding to private equity health deals - The Business Times
Blackstone buys Japan drug trial firm, adding to private equity health deals The Business Times
Healthcare, Pharmaceutical, Biotechnology, Clinical Research & MedTech Industry News
Blackstone buys Japan drug trial firm, adding to private equity health deals The Business Times
Sumitomo Pharma America Presents First Clinical Data for SMP-3124LP, an Investigational PEGylated Liposome CHK1 Inhibitor, at ASCO 2026 BioSpace
Clinical Overview of Listeriosis | Listeria Infection Centers for Disease Control and Prevention | CDC (.gov)